載入...
Treatment Optimization for Brain Metastasis from Anaplastic Lymphoma Kinase Rearrangement Non-Small-Cell Lung Cancer
BACKGROUND: Brain metastasis is common in non-small-cell lung cancer (NSCLC) with driver gene mutations. Anaplastic lymphoma kinase (ALK) gene rearrangement is one of the common driver mutations in NSCLC. Tyrosine kinase inhibitor (TKI) has been the research hotspot at present. However, there are re...
Na minha lista:
| 發表在: | Oncol Res Treat |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
S. Karger AG
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6921697/ https://ncbi.nlm.nih.gov/pubmed/31527380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000502755 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|